Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01569529 · ClinicalTrials.gov registry record
Young Adult Smoker's Treatment Demand
A clinical trial of Smoking Cessation, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- 3,070
- Enrollment target
- 1
- Study location
NCT01569529: Completed study of Smoking Cessation, sponsored by University of Illinois at Chicago.
NCT01569529 is a study of Smoking Cessation that has completed, run by University of Illinois at Chicago. The registered enrollment target is 3,070 participants, above the 458-participant average among 188 other Smoking Cessation trials with a reported enrollment target (570% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01569529, a study of Smoking Cessation, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- 3,070 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether tailored online advertisements will drive young adult smoker's (18 to 26 years old), who are motivated to quit, to use Internet-based cessation treatment.
Primary Outcome
Rates of enrollment will be calculated as the proportion of visitors who enroll in treatment (e.g., number of enrollments/number of click-throughs from banner ads).
Conditions Studied
Interventions
- BEHAVIORAL Online advertisement
Study Locations (1)
Illinois
- Institute for Health Reseach and Policy, UIC - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,070 participants |
| Start Date | 2012-05 |
| Est. Completion | 2012-11 |
What the finished NCT01569529 record still lists
NCT01569529 is an observational study that tracks outcomes without assigning an intervention. Its 3,070 participants enrollment target places it among the larger protocols in the corpus, above the 458-participant average among 188 other Smoking Cessation trials with a reported enrollment target (570% higher).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which Online advertisement is the first listed.
NCT01569529 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT01569529 about?
NCT01569529 is a clinical study titled "Young Adult Smoker's Treatment Demand". The purpose of this study is to determine whether tailored online advertisements will drive young adult smoker's (18 to 26 years old), who are motivated to quit, to use Internet-based cessation treatment.
What is the current status of trial NCT01569529?
This trial is currently completed. The enrollment target is 3,070 participants. The study started on 2012-05. Estimated completion is 2012-11.
What conditions does trial NCT01569529 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT01569529?
The interventions under investigation include: Online advertisement (BEHAVIORAL).
Who is sponsoring clinical trial NCT01569529?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01569529 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01569529's enrollment target sits among peer trials
3,070 4th of 188 higher than 185 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
RECRUITING
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06667700 · 3,082 participants · Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- NCT05534243 · 3,090 participants · NA
The ED-AWARENESS-2 Trial
- NCT04722822 · 3,100 participants · NA
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
- NCT07116967 · 3,040 participants · Phase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia